Federated Hermes
DNLI icon

Federated Hermes’s Denali Therapeutics DNLI Stock Holding History

Federated Hermes’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,351,900
Closed -$29M – 2053
2023
Q4 		$29M Hold
1,351,900
– – 0.07% 301
2023
Q3 		$27.9M Buy
1,351,900
+288,400
+27% +$7.32M 0.07% 291
2023
Q2 		$31.4M Hold
1,063,500
– – 0.08% 293
2023
Q1 		$24.5M Buy
1,063,500
+288,500
+37% +$7.94M 0.06% 337
2022
Q4 		$21.6M Buy
775,000
+118,407
+18% +$3.52M 0.06% 365
2022
Q3 		$20.2M Sell
656,593
-12,336
-2% -$401K 0.06% 377
2022
Q2 		$19.7M Sell
668,929
-236,316
-26% -$6.19M 0.05% 395
2022
Q1 		$29.1M Buy
905,245
+169,813
+23% +$5.84M 0.07% 355
2021
Q4 		$32.8M Buy
735,432
+396,272
+117% +$18.8M 0.06% 363
2021
Q3 		$17.1M Buy
339,160
+200,528
+145% +$11.3M 0.03% 516
2021
Q2 		$10.9M Buy
138,632
+8,672
+7% +$536K 0.02% 625
2021
Q1 		$7.42M Sell
129,960
-104,240
-45% -$6.98M 0.01% 744
2020
Q4 		$19.6M Buy
234,200
+106,005
+83% +$6.41M 0.04% 475
2020
Q3 		$4.59M Sell
128,195
-149,268
-54% -$4.5M 0.01% 746
2020
Q2 		$6.71M Buy
+277,463
New +$6.52M 0.02% 632
2019
Q3 		– Sell
-103,755
Closed -$2.15M – 2225
2019
Q2 		$2.15M Buy
103,755
+833
+0.8% +$18.7K 0.01% 1035
2019
Q1 		$2.39M Buy
+102,922
New +$2.15M 0.01% 991

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return